New predictive window to Kidney Health
The Serenno system is a pioneering Urine Output (UO) Monitor
for hospitalized patients improving
Acute Kidney Injury (AKI) prediction
and fluid management.
Â
The problem
Acute Kidney Injury (AKI) - an avoidable, dangerous and common complication that affects 19 million patients worldwide every year.
AKI is hard to treat and reverse once it manifests fully.
Â
The Solution
Continuous UO measurement - the only reliable way to detect, assess, possibly anticipate AKI occurrence.
Earlier AKI detection – reduces patient risk and renders most cases preventable.
Â
The Serenno system advantages:

Fully automatic, low workload, hands free

EMR Connected, delivering more actionable data

Safe, robust and reliable for every patient

Low cost, easy to use, streamline into the ICU
Â
Unique use options

ER>OR>ICU mobility

Quarantine
ICU

Telehealth/
Remote ICU

Home
ICU
Â
Â
Team
The Serenno team combines over 70 years of experience in all aspects of the medical device business.

Tomer Lark
CEO, Founder

Noam Hadas
CTO, Founder

Sagie Meshulam
VP R&D
Â

Â
Contact
Â